We are upgrading the repository! A content freeze is in effect until December 6, 2024. New submissions or changes to existing items will not be allowed during this period. All content already published will remain publicly available for searching and downloading. Updates will be posted in the Website Upgrade 2024 FAQ in the sidebar Help menu. Reach out to escholarship@umassmed.edu with any questions.
Health-related quality of life of heart failure and coronary artery disease patients improved during participation in disease management programs: a longitudinal observational study
Authors
Martin, MarieBlaisdell-Gross, Bonnie
Fortin, Elizabeth W.
Maruish, Mark E.
Manocchia, Michael
Sun, Xiaowu
Walker, David R.
Apple, Joanna L.
Ware, John E. Jr.
UMass Chan Affiliations
Department of Quantitative Health SciencesDocument Type
Journal ArticlePublication Date
2007-06-26Keywords
AdultAged
Aged, 80 and over
Coronary Artery Disease
Cost of Illness
*Disease Management
Female
Health Surveys
Heart Failure
Humans
Male
Middle Aged
Program Development
*Program Evaluation
Prospective Studies
*Quality of Life
Questionnaires
*Sickness Impact Profile
Biostatistics
Epidemiology
Health Services Research
Metadata
Show full item recordAbstract
The objective of the study was to examine the burden of coronary artery disease (CAD) and heart failure (HF) on health-related quality of life (HRQOL) and the HRQOL trajectory among participants in a disease management (DM) program characterized by personalized models of education, counseling, and supportive contact. In all, 2,590 CAD and 3,182 HF patients were assessed at baseline and at 3, 6, 9, and 12 months post-enrollment. HRQOL was measured via a computerized dynamic test, whose core consisted of SF-8 items. HRQOL burden was assessed by comparing physical component summary (PCS) and mental component summary (MCS) scores to demographically adjusted US norms and to historical controls. Disease trajectories were assessed with change score analyses and by a categorization of participants as improving, stable, or deteriorating. Among the results, both groups showed between 1.7 to 2.6 times the likelihood of improving over worsening after a full year of DM participation in all measures. In contrast, historical controls experienced no significant HRQOL improvement or decline after 2 years of standard treatment. After 1 or 2 years they were more likely to decline than to improve in their PCS scores and were about as likely to improve as to worsen in their MCS scores. In conclusion, HF places a substantial burden on HRQOL, and the burden of CAD is also noticeable. While the study design does not allow causal interpretations, HRQOL significantly improved for both CAD and HF patients during DM program participation. This trend is in contrast to historic controls, where no significant HRQOL improvement occurred over time.Source
Dis Manag. 2007 Jun;10(3):164-78. Link to article on publisher's siteDOI
10.1089/dis.2007.103612Permanent Link to this Item
http://hdl.handle.net/20.500.14038/47467PubMed ID
17590147Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.1089/dis.2007.103612